Concenter BioPharma
CEO & Founder: Dror Chevion
Stage: Clinical trials
Year Established: 2019
Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., is developing a novel drug for treating and preventing type 2 diabetes. This drug act as:
JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)